Friday, August 16, 2024 6:21:00 PM
I am a legacy shareholder however I quintupled down and bought enough lower priced shares to move my average share price down to 68 cents before buying some more higher priced shares that moved my average up to about 72 cents, and finally buying more 30-something shares (still buying) and haven’t figured my current average but the share price must be close to half my average share price now.
So I would break even somewhere around 70 cents and go quickly positive above that.
Even at $5 nwbo would return quite nicely, and anything around $10 would result in my largest single stock gain. Multiples of $10 such as $20, $30, … would indeed be generational territory.
Did we invest a pretty significant amount of money, yes!
Is the risk reward worth it? Imo yes!!!
Would I survive a total loss, depends on how good my wife is with weapons or poisons, and given the perpetual “I told you so” treatment it’s a quick finish vs a death of many cuts
So I would break even somewhere around 70 cents and go quickly positive above that.
Even at $5 nwbo would return quite nicely, and anything around $10 would result in my largest single stock gain. Multiples of $10 such as $20, $30, … would indeed be generational territory.
Did we invest a pretty significant amount of money, yes!
Is the risk reward worth it? Imo yes!!!
Would I survive a total loss, depends on how good my wife is with weapons or poisons, and given the perpetual “I told you so” treatment it’s a quick finish vs a death of many cuts
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
